|

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

RECRUITINGPhase 4Sponsored by Mansoura University
Actively Recruiting
PhasePhase 4
SponsorMansoura University
Started2023-08-15
Est. completion2025-08
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07132515

Summary

We will give an anticoagulant against portal vein thrombosis, and watch for the results.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Portal vein thrombosis, Cirrhosis, With or without HCC, Child A \& B

Exclusion Criteria:

* Platelets\<10000, Createnine \>1.9, Budd ciarri, Uncontrolled active bleeding

Conditions6

CancerCirrhosisHCC - Hepatocellular CarcinomaLiver CancerLiver DiseasePortal Vein Thrombosis

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.